Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the…
Gujarat Themis Biosyn's Rs 3,000 crore bet: Can it build a global pharma platform?
Let us understand what these deals mean for the business, and whether the numbers support the ambition. To understand the implications, let's examine the company's business model and assess whether the numbers support its ambitions. Founded in…
Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out
The weight-loss drug market may be one of the fastest-growing therapeutic areas in the pharmaceutical industry. Eli Lilly (LLY 1.57%) has been a major winner from this boom. The drugmaker's Zepbound is one of the best-selling anti-obesity…
Aurobindo Pharma sets up TheraNym, a dedicated biologics contract manufacturing body
Aurobindo Pharma inaugurated TheraNym, a dedicated biologics contract manufacturing organisation (CMO), marking its foray into biologics contract manufacturing. The Hyderabad-based company hopes to harness the global potential in the biologics…
Canaccord Genuity Group Initiates Coverage on BridgeBio Pharma (NASDAQ:BBIO)
Research analysts at Canaccord Genuity Group started coverage on shares of BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a 'buy' rating and a $104.00 price…
What India, US Accomplish Together Will Shape the Future, It is 'Most Consequential Global Partnership of the Century': US Ambassador Sergio Gor
Mumbai, Maharashtra: The partnership between India and the United States is 'the most consequential global partnership of the century', US Ambassador to India Sergio Gor said on Wednesday and noted that what the two nations accomplish together will…
Apoha, a startup using building AI based on new liquid 'wave form' data, emerges from stealth with $36 million Series A round
Apoha, a deep tech startup that is building AI models for creating new kinds of substances—from proteins to food products to paints—based on a new kind of data about how materials behave, is emerging from stealth today with $36…
Stock Market Opening Bell: Sensex Declines 0.19%, Nifty 50 Plummets 0.29% - Here's Why
Stock Market Opening Bell: India's benchmark stock market equity bourses Sensex and Nifty 50 witnessed a gap down opening on Wednesday June 3, tracking global market cues, including developments linked to the West Asia conflict. While Sensex fell…
Trump's grip on GOP weakens as he suffers shock defeat in Iowa
A Donald Trump-endorsed candidate suffered a narrow primary defeat to a candidate backed by the Make America Healthy Again (MAHA) movement on Tuesday—in the first loss for a Trump-endorsee in the 2026 midterms election cycle. Representative…
Appian: Tech Platform With Margin And Cashflow Recovery Trends, Despite Q1 Net Loss (APPN)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Why The New CMO Divide Is AI Readiness
Trish Nettleship is the SVP of Marketing at Toshiba Global Commerce Solutions. She writes about marketing, communications, and leadership. For the first time in years, the difference in marketing leadership is not just about strategy or experience.
Avalyn: Q1 Earnings Snapshot
BOSTON (AP) — BOSTON (AP) — Avalyn Pharma Inc. (AVLN) on Wednesday reported a loss of $26.9 million in its first quarter. The Boston-based company said it had a loss of $21.83 per share. This story was generated by Automated Insights…
TheraNyM Biologics opens ₹1,200 crore manufacturing facility near Hyderabad
A ₹1,200 crore manufacturing facility of generic drugmaker Aurobindo Pharma's subsidiary TheraNyM Biologics near Hyderabad, with a potential to generate more than 1,500 jobs for the local youth, was opened on Wednesday (June 3, 2026).
Celcuity: Selloff On Yesterday's Data Unwarranted; Buy Rating Upheld (NASDAQ:CELC)
Celcuity shares dropped over 25% despite Phase 3 VIKTORIA-1 data confirming gedatolisib's best-in-class efficacy in advanced breast cancer. Gedatolisib demonstrated superior progression-free survival and objective response rates versus current…
Trump must crack down on middlemen amid drug affordability crisis
Although the Trump administration is taking steps to investigate insurer and PBM practices, it's time for it to crack down on these bad actors once and for all. Insurers and PBMs frequently force patients to jump through a maze of hoops to access…
Receive a Daily briefing on Pharma Industry News
Get Started